|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, amortization and accretion | |||||
| Provision for credit losses on loans | |||||
| Provision for credit losses on unfunded loan commitments | |||||
| Deferred income tax benefit | |||||
| Stock-based compensation expense | |||||
| Excess tax benefit from exercise of SSARs | |||||
| Proceeds from sale of loans held-for-sale | |||||
| Originations of loans held-for-sale | |||||
| Earnings from bank-owned life insurance | |||||
| Gain from bank-owned life insurance claim | |||||
| Net gain from sales of loans | |||||
| Net loss from sales of investment securities | |||||
| Net gain from sale and write-down of foreclosed assets held-for-sale | |||||
| Net (gain) loss from write-down and disposal of bank premises and equipment | |||||
| Operating lease payments | |||||
| Change in: | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Accrued interest payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sales | |||||
| Proceeds from maturities, calls and principal pay-downs | |||||
| Purchases | |||||
| Increase in restricted investments in bank stock | |||||
| Net increase in loans and leases | |||||
| Principal portion of lease payments received under direct finance leases | |||||
| Purchase of bank-owned life insurance policies | |||||
| Purchases of bank premises and equipment | |||||
| Purchases of tax credits | |||||
| Proceeds from death benefits received on bank-owned life insurance | |||||
| Proceeds from sale of bank premises and equipment | |||||
| Proceeds from sale of foreclosed assets held-for-sale | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase in deposits | |||||
| Net decrease in borrowings | |||||
| Repayment of finance lease obligation | |||||
| Purchase of treasury stock | |||||
| Proceeds from employee stock purchase plan participants | |||||
| Repurchase of shares to cover withholdings | |||||
| Dividends paid, net of dividends reinvested | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning | |||||
| Cash and cash equivalents, ending | |||||
| Supplemental Disclosures of Cash Flow Information | |||||
| Interest | |||||
| Income tax | |||||
| Federal taxes | |||||
| State taxes | |||||
| Supplemental Disclosures of Non-cash Investing Activities: | |||||
| Net change in unrealized losses on available-for-sale securities | |||||
| Transfers of securities from available-for-sale to held-to-maturity | |||||
| Unrealized losses on securities transferred from available-for-sale to held-to-maturity | |||||
| Cumulative-effect adjustment for adoption of ASU 2016-13 | |||||
| Amortization of unrealized losses on securities transferred from available-for-sale to held-to-maturity | |||||
| Transfers from loans to foreclosed assets held-for-sale | |||||
| Transfers from/(to) loans to/(from) foreclosed assets held-for-sale | |||||
| Transfers from loans to loans held-for-sale, net | |||||
| Transfers from premises and equipment to other assets held-for-sale | |||||
| Net change in right-of-use asset | |||||
| Goodwill | |||||
| Total goodwill | |||||
| Net change in lease liability | |||||
Loading...